News Tag: Regulatory

Changes in Precise Biometrics’ management team

Fredrik Sjöholm has today announced his intention to pursue new challenges outside of Precise to assume the role as CEO for another company, and thereby leaving the role as EVP and CCO Algo for Precise. Fredrik will remain in his role during his notice period, which amounts to six months.

Read More

Precise Biometrics announces outcome of rights issue and directed issue

The board of directors of Precise Biometrics AB today announces the outcome of the rights issue of ordinary shares which was resolved on by the board of directors on 10 August 2022 and approved by the extraordinary general meeting on 5 September 2022. In total, 2,871,564 ordinary shares were subscribed for, corresponding to approximately 43.5 percent of the rights issue. Through the rights issue, the company will receive approximately SEK 18.5 million prior to issue costs. Further, Egis Technology Inc. has subscribed and been allocated all ordinary shares in the directed issue resolved on by the board of directors on 10 August 2022, corresponding to proceeds of approximately SEK 25.5 million before issue costs. In total, the Company will receive approximately SEK 44.0 million before issue costs. Egis Technology’s ownership in the Company after the share issues amounts to a total of 5,609,488 ordinary shares, corresponding to 12.08 percent of the shares in the Company.

Read More

Precise announces management changes to support growth strategy

Precise today announces management changes to reflect its business segments Algo and Digital Identity. The changes are made to support continued delivery in accordance with the growth strategy and provide a strengthened focus on Precise’s two business segments. As a result of the re-organization, the Board of Directors has appointed Fredrik Sjöholm as EVP and CCO of Algo. At the same time, Patrick Höijer will assume the role as interim CCO of Digital Identity in addition to his role as CEO.

Read More

Precise Biometrics publishes prospectus

Precise Biometrics AB (”Precise” or the ”Company”) has prepared a prospectus by reason of the directed issue of up to 3,959,639 ordinary shares to Egis Technology Inc., the rights issue of up to 6,599,399 ordinary shares, and the over-allotment option of up to 2,339,787 ordinary shares, which were announced by the Company on 10 August 2022.

Read More

Extraordinary general meeting of Precise Biometrics AB

The extraordinary general meeting (EGM) of Precise Biometrics AB took place on 5 September 2022. The EGM resolved in line with all of the proposals presented in the notification to attend the EGM. For complete information, see the notice to attend the EGM on the company's website. Resolution to approve the board of directors’ resolution […]

Read More

Precise Biometrics AB resolves on a directed issue to Egis Technology of up to SEK 25.5 million as well as a rights issue of up to SEK 42.5 million (with an over-allotment option of up to SEK 15.1 million)

The Board of Directors of Precise Biometrics AB has today, on the basis of the authorization from the Annual General Meeting held on 19 May 2022, resolved on a directed issue of up to 3,959,639 ordinary shares, corresponding to 10 percent of outstanding shares in the company, to Egis Technology Inc. Furthermore, subject to subsequent approval by the Extraordinary General Meeting, the Board of Directors has resolved on a rights issue of up to 6,599,399 ordinary shares as well as resolved to submit a proposal for an issue authorization linked to an over-allotment option of up to 2,339,787 ordinary shares. Egis Technology Inc. has committed to subscribe for the shares in the directed issue, guarantee approximately a fourth of the rights issue free of charge and to subscribe for shares in the over-allotment option to the extent necessary for Egis Technology Inc.’s ownership in the company to amount to approximately 12.0 percent of the shares in the company after the issues. Notice of an Extraordinary General Meeting, scheduled for 5 September 2022, will be announced by a separate press release.

Read More